ACTU
Actuate Therapeutics Inc
NASDAQHealthcareBiotechnologyUS
USD1.82
-0.06 (-3.19%)
Rating:C
Company Profile
CEO
Daniel Schmitt
IPO Date
2024-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.89
Prev. Close
$1.88
Day Low
$1.81
Day High
$1.89
52W Low
$1.58
52W High
$9.35
Market Cap
$0.04B
Volume
0.08M